Clinical Trial: Autologous Adipose-Derived Stem Cell Injections for Knee Osteoarthritis

U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07901790) titled 'Autologous Adipose-Derived Stem Cell Injections for Knee Osteoarthritis' on Oct. 22.

Brief Summary: This multicenter, prospective, randomized, active-controlled, single-blind (assessor-blinded) clinical trial aims to evaluate the efficacy and safety of intra-articular injection of autologous adipose-derived mesenchymal stem cells (ADMSCs) compared with active comparator hyaluronic acid (HA) in patients with Kellgren-Lawrence grade II to III knee osteoarthritis. A total of 165 participants across 3 centers (Severance Hospital, Seoul National University Hospital, Inha University Hospital) will be randomly allocated to either the ADMSC...